178 related articles for article (PubMed ID: 29369538)
1. Long-term uveal melanoma survivors: measuring their quality of life.
Frenkel S; Rosenne H; Briscoe D; Hendler K; Bereket R; Molcho M; Pe'er J
Acta Ophthalmol; 2018 Jun; 96(4):e421-e426. PubMed ID: 29369538
[TBL] [Abstract][Full Text] [Related]
2. Translation and validation of the Polish version of the EORTC QLQ-OPT30 module for the assessment of health-related quality of life in patients with uveal melanoma.
Chmielowska K; Tomaszewski KA; Pogrzebielski A; Brandberg Y; Romanowska-Dixon B
Eur J Cancer Care (Engl); 2013 Jan; 22(1):88-96. PubMed ID: 22966840
[TBL] [Abstract][Full Text] [Related]
3. The use of semistructured interviews to assess quality of life impacts for patients with uveal melanoma.
Kopp BC; Crump RT; Weis E
Can J Ophthalmol; 2017 Apr; 52(2):181-185. PubMed ID: 28457288
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.
Klingenstein A; Fürweger C; Mühlhofer AK; Leicht SF; Schaller UC; Muacevic A; Wowra B; Hintschich C; Eibl KH
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):1005-12. PubMed ID: 26573389
[TBL] [Abstract][Full Text] [Related]
5. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S; ;
Eye (Lond); 2004 Mar; 18(3):283-9. PubMed ID: 15004578
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma.
Gollrad J; Rabsahl C; Riechardt AI; Heufelder J; Stroux A; Goerling U; Joussen A; Budach V; Boehmer D
Radiat Oncol; 2021 Sep; 16(1):174. PubMed ID: 34496895
[TBL] [Abstract][Full Text] [Related]
7. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study.
Brandberg Y; Kock E; Oskar K; af Trampe E; Seregard S
Eye (Lond); 2000 Dec; 14(Pt 6):839-46. PubMed ID: 11584839
[TBL] [Abstract][Full Text] [Related]
8. Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.
van Beek JGM; Buitendijk GHS; Timman R; Muller K; Luyten GPM; Paridaens D; Naus NC; Kiliç E
Acta Ophthalmol; 2018 Dec; 96(8):841-848. PubMed ID: 30284368
[TBL] [Abstract][Full Text] [Related]
9. Quality of Life in Uveal Melanoma Patients in Ireland: A Single-Centre Survey.
Scannell O; O'Neill V; Dunne M; Baily C; Salih A; Cunningham M; Horgan N
Ocul Oncol Pathol; 2020 Mar; 6(2):99-106. PubMed ID: 32258017
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
Hechtner M; Eichler M; Wehler B; Buhl R; Sebastian M; Stratmann J; Schmidberger H; Gohrbandt B; Peuser J; Kortsik C; Nestle U; Wiesemann S; Wirtz H; Wehler T; Bals R; Blettner M; Singer S
J Thorac Oncol; 2019 Mar; 14(3):420-435. PubMed ID: 30508641
[TBL] [Abstract][Full Text] [Related]
11. Patient-reported Outcomes and Quality of Life After Treatment of Choroidal Melanoma: A Comparison of Enucleation Versus Radiotherapy in 1596 Patients.
Damato B; Hope-Stone L; Cooper B; Brown SL; Salmon P; Heimann H; Dunn LB
Am J Ophthalmol; 2018 Sep; 193():230-251. PubMed ID: 29555484
[TBL] [Abstract][Full Text] [Related]
12. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life Concerns in Patients with Uveal Melanoma after Initial Diagnosis.
Barker CA; Kozlova A; Shoushtari AN; Hay JL; Francis JH; Abramson DH
Ocul Oncol Pathol; 2020 May; 6(3):184-195. PubMed ID: 32509764
[TBL] [Abstract][Full Text] [Related]
14. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.
Winstanley JB; Young TE; Boyle FM; Bergenmar M; Bottomley A; Burmeister B; Campana LG; Garioch JJ; King M; Nikolic DV; van de Poll-Franse LV; Saw R; Thompson JF; White EG;
Melanoma Res; 2015 Feb; 25(1):47-58. PubMed ID: 25325247
[TBL] [Abstract][Full Text] [Related]
15. The national comprehensive cancer network distress thermometer as a screening tool for the evaluation of quality of life in uveal melanoma patients.
Klingenstein A; Samel C; Garip-Kuebler A; Miller C; Liegl RG; Priglinger SG; Foerster PI
Acta Ophthalmol; 2020 May; 98(3):e381-e387. PubMed ID: 31654488
[TBL] [Abstract][Full Text] [Related]
16. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
[TBL] [Abstract][Full Text] [Related]
17. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
Ozturk A; Sarihan S; Ercan I; Karadag M
Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Korean Version of the Quality of Life-Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors.
Cho J; Kang D; Kim IR; Kim WS; Ferrell B; Kim SJ
Cancer Res Treat; 2018 Jan; 50(1):204-211. PubMed ID: 28361524
[TBL] [Abstract][Full Text] [Related]
19. Health related quality of life (HRQOL) in long-term survivors of pediatric low grade gliomas (LGGs).
Nwachukwu CR; Youland RS; Chioreso C; Wetjen N; NageswaraRao A; Keating G; Laack NN
J Neurooncol; 2015 Feb; 121(3):599-607. PubMed ID: 25467557
[TBL] [Abstract][Full Text] [Related]
20. Survival from uveal melanoma in Western Australia 1981-2005.
Chew AL; Spilsbury K; Isaacs TW
Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
